Skip to content

C50.422 ICD-10-CM Code: Malignant neoplasm of upper-outer quadrant of left male breast

ICD-10-CM Code View

HCC Buddy Code Card

Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.

FY 2026 Apr update / Neoplasms (C00-D49) / Malignant neoplasms of breast (C50)

C50.422

Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidance

Malignant neoplasm of upper-outer quadrant of left male breast

Cancer that develops in the upper-outer area of the left breast in men. Male breast cancer is uncommon but requires specific coding.

Buddy the Bee presenting code insight

Buddy Insight

Male breast cancer of the upper-outer quadrant of the left breast is a rare malignancy accounting for less than 1% of all breast cancers.

CMS-HCC V28

0

0

RAF 0

CMS-HCC V24

HCC 12

RAF 0.150

ACA/HHS

0

0

RAF 0

ESRD/PACE

HCC 12

RAF 0.0

RXHCC

HCC 22

RAF 0.0

Code Trumping

Basket needed

Code Book Path

Official
C50.4Malignant neoplasm of upper-outer quadrant of breast
C50.42Malignant neoplasm of upper-outer quadrant of breast, male
C50.422Malignant neoplasm of upper-outer quadrant of left male breast

Inclusion Terms

Official

ICD-10-CM does not list inclusion terms for C50.422 in this effective period.

Excludes 2

Official

ICD-10-CM does not list Excludes 2 notes for C50.422 in this effective period.

Related Child Codes

Official
C50.421Malignant neoplasm of upper-outer quadrant of right male breast
C50.429Malignant neoplasm of upper-outer quadrant of unspecified male breast

Includes

Official

ICD-10-CM does not list Includes notes for C50.422 in this effective period.

Excludes 1

Official

ICD-10-CM does not list Excludes 1 notes for C50.422 in this effective period.

Code First

Official

ICD-10-CM does not list Code First sequencing instructions for C50.422 in this effective period.

Use Additional

Official

ICD-10-CM does not list Use Additional Code instructions for C50.422 in this effective period.

Code Also

Official

ICD-10-CM does not list Code Also instructions for C50.422 in this effective period.

Buddy Documentation Tip

HCC Buddy guidance
Confirmed male patient sex
Laterality documented as left breast
Specific quadrant identified as upper-outer
Histological type (invasive ductal carcinoma is most common in males)

MEAT Support

HCC Buddy guidance
Confirmed male patient sex
Laterality documented as left breast
Specific quadrant identified as upper-outer
Histological type (invasive ductal carcinoma is most common in males)

Audit Caution

HCC Buddy guidance
Confusing male (x2x) and female (x1x) breast cancer codes — the 4th digit distinguishes gender
Failing to query for laterality when documentation is ambiguous, defaulting to unspecified
Using history of cancer code (Z85.19) when the patient still has active disease
Not capturing concurrent metastatic codes when disease has spread beyond the primary site

Common Mistakes

HCC Buddy guidance
C50.412 — Malignant neoplasm of upper-outer quadrant of left female breast; coders confuse the 4th character (1=female, 2=male) which drives gender-specific coding
C50.429 — Malignant neoplasm of upper-outer quadrant of unspecified male breast; used only when laterality is unknown, but coders default to unspecified instead of querying
C50.922 — Malignant neoplasm of unspecified site of left male breast; less specific site designation when the quadrant is actually documented

Last updated: FY2026 ICD-10-CM Apr update, Apr 1, 2026 through Sep 30, 2026. CMS-HCC V28 is 100% phased in for payment year 2026.

Is C50.422 an HCC code?

Yes. C50.422 maps to Breast, Prostate, and Other Cancers and Tumors under the V24 model but is not retained in V28.

HCC Category Mapping

V24HCC 12, Breast, Prostate, and Other Cancers and Tumors
0.150
ESRDHCC 12, Breast, Prostate, and Other Cancers and Tumors
0.000
RxHCCHCC 22, Cancer, Other Specified Sites
0.000

RAF weights shown are the community, non-dual, aged base weights from the CMS risk adjustment model file. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.

MEAT Criteria for C50.422

For C50.422to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically, it has to be re-documented and supported each calendar year.

  • MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
  • EEvaluate: test results, medication response, or physical findings reviewed by the provider
  • AAssess: explicit mention in the assessment or plan with acknowledgment of status
  • TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis

Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed C50.422 during that encounter, not just copy-forwarded from a problem list.

What This Code Means

C50.422 is the ICD-10-CM diagnosis code for malignant neoplasm of upper-outer quadrant of left male breast. Cancer that develops in the upper-outer area of the left breast in men. Male breast cancer is uncommon but requires specific coding. C50.422 sits in the ICD-10-CM chapter for neoplasms (c00-d49), within the section covering malignant neoplasms of breast (c50).

Under the older CMS-HCC V24 model, C50.422 maps to Breast, Prostate, and Other Cancers and Tumors (HCC 12) with a community, non-dual, aged base RAF weight of 0.150. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.

Verify male gender and left breast location in the documentation. Because C50.422 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.

HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for C50.422 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.

Coding Tips

  • Verify male gender and left breast location in the documentation
  • Remember that male breast cancer codes differ from female codes in the 4th digit position

Clinical Significance

Male breast cancer of the upper-outer quadrant of the left breast is a rare malignancy accounting for less than 1% of all breast cancers. Accurate site and laterality documentation is critical for staging, surgical planning, and risk adjustment, as male breast cancers often present at later stages due to delayed detection.

Documentation Requirements

  • Confirmed male patient sex
  • Laterality documented as left breast
  • Specific quadrant identified as upper-outer
  • Histological type (invasive ductal carcinoma is most common in males)
  • Tumor stage (TNM classification)
  • Receptor status (estrogen receptor, progesterone receptor, HER2) when available
  • Current treatment status (active treatment, surveillance, or history of)

Commonly Confused Codes

  • C50.412 — Malignant neoplasm of upper-outer quadrant of left female breast; coders confuse the 4th character (1=female, 2=male) which drives gender-specific coding
  • C50.429 — Malignant neoplasm of upper-outer quadrant of unspecified male breast; used only when laterality is unknown, but coders default to unspecified instead of querying
  • C50.922 — Malignant neoplasm of unspecified site of left male breast; less specific site designation when the quadrant is actually documented

Child Codes

Code Hierarchy

More on C50.422

Related condition guides

Open C50.422 in the Interactive Encoder

See full code details, coding tips, HCC mappings, and related codes in our interactive encoder. Start your 14-day Pro trial. No credit card required.